Reuters logo
BRIEF-Halozyme provides update on SWOG Collaborative Group clinical study
March 30, 2017 / 1:12 PM / 8 months ago

BRIEF-Halozyme provides update on SWOG Collaborative Group clinical study

March 30 (Reuters) - Halozyme Therapeutics Inc:

* Halozyme provides update on swog collaborative group clinical study

* SWOG phase 1B/2 trial has been temporarily closed to enrollment

* Halozyme - Halozyme is working with SWOG to verify and analyze initial data set following completion of retrospective determination of tumor HA levels

* Halozyme-Addition of PEGPH20 given every two weeks unlikely to demonstrate statistically significant improvement in primary endpoint of overall survival Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below